Published in Gastroenterology on March 01, 2006
Esophageal motility disorders in terms of pressure topography: the Chicago Classification. J Clin Gastroenterol (2008) 3.36
The contractile deceleration point: an important physiologic landmark on oesophageal pressure topography. Neurogastroenterol Motil (2009) 2.34
Functional esophagogastric junction obstruction with intact peristalsis: a heterogeneous syndrome sometimes akin to achalasia. J Gastrointest Surg (2009) 2.14
Distal esophageal spasm in high-resolution esophageal pressure topography: defining clinical phenotypes. Gastroenterology (2011) 2.05
History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Gastroenterology (2010) 2.05
Multimorbidity patterns in primary care: interactions among chronic diseases using factor analysis. PLoS One (2012) 1.71
Body mass index and Barrett's oesophagus in women. Gut (2009) 1.70
Impedance pH confirms the relationship between GERD and BMI. Dig Dis Sci (2012) 1.57
Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2013) 1.56
High-resolution manometry and impedance-pH/manometry: valuable tools in clinical and investigational esophagology. Gastroenterology (2008) 1.51
Lifestyle Intervention in Gastroesophageal Reflux Disease. Clin Gastroenterol Hepatol (2015) 1.47
Unique features of esophagogastric junction pressure topography in hiatus hernia patients with dysphagia. Surgery (2009) 1.46
Association of adiponectin multimers with Barrett's oesophagus. Gut (2009) 1.43
Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol (2012) 1.41
Utilizing intraluminal pressure gradients to predict esophageal clearance: a validation study. Am J Gastroenterol (2008) 1.39
Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol (2012) 1.30
Symptomatic reflux disease: the present, the past and the future. Gut (2014) 1.29
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology (2015) 1.21
Body weight, lifestyle, dietary habits and gastroesophageal reflux disease. World J Gastroenterol (2009) 1.18
Diet, lifestyle and gender in gastro-esophageal reflux disease. Dig Dis Sci (2007) 1.16
Gene-environment interactions controlling energy and glucose homeostasis and the developmental origins of obesity. Physiol Rev (2015) 1.10
Gastroesophageal reflux disease: From pathophysiology to treatment. World J Gastroenterol (2010) 1.06
Gastroesophageal reflux disease and severe obesity: Fundoplication or bariatric surgery? World J Gastroenterol (2010) 1.02
Distribution of body fat and its influence on esophageal inflammation and dysplasia in patients with Barrett's esophagus. Clin Gastroenterol Hepatol (2012) 1.02
Association of Serum Levels of Adipokines and Insulin With Risk of Barrett's Esophagus: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol (2015) 1.02
Barrett's esophagus: Incidence, etiology, pathophysiology, prevention and treatment. Ther Clin Risk Manag (2007) 1.00
Esophageal motility abnormalities in gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther (2014) 0.99
Association of Barrett's esophagus with type II Diabetes Mellitus: results from a large population-based case-control study. Clin Gastroenterol Hepatol (2013) 0.95
The pathophysiological mechanisms of GERD in the obese patient. Dig Dis Sci (2008) 0.94
High-resolution manometry: an atlas of esophageal motility disorders and findings of GERD using esophageal pressure topography. Thorac Surg Clin (2011) 0.93
Effect of high fat-diet and obesity on gastrointestinal motility. Ann Transl Med (2013) 0.92
Esophageal malignancy: a growing concern. World J Gastroenterol (2012) 0.92
The role of obesity in oesophageal cancer development. Therap Adv Gastroenterol (2014) 0.90
Optimal treatment of laryngopharyngeal reflux disease. Ther Adv Chronic Dis (2013) 0.90
Recent concept in interpreting high-resolution manometry. J Neurogastroenterol Motil (2010) 0.89
Gastroesophageal reflux disease and morbid obesity: is there a relation? World J Surg (2009) 0.88
Association between metabolic syndrome and prevalence of gastroesophageal reflux disease in a health screening facility in Japan. J Gastroenterol (2012) 0.87
Prevalence and risk factors for gastroesophageal reflux disease in an impoverished minority population. Obes Res Clin Pract (2010) 0.87
Effects of estrogen with and without progestin and obesity on symptomatic gastroesophageal reflux. Gastroenterology (2008) 0.86
The effect of bariatric surgery on gastroesophageal reflux disease. Can J Surg (2014) 0.85
The effect of abdominal visceral fat, circulating inflammatory cytokines, and leptin levels on reflux esophagitis. J Neurogastroenterol Motil (2015) 0.84
Pathophysiological mechanisms linking obesity and esophageal adenocarcinoma. World J Gastrointest Pathophysiol (2014) 0.84
Treatment of GORD: Three decades of progress and disappointments. United European Gastroenterol J (2013) 0.84
Diaphragmatic relaxing incisions during laparoscopic paraesophageal hernia repair. Surg Endosc (2013) 0.84
Gastro-esophageal reflux disease and obesity, where is the link? World J Gastroenterol (2013) 0.83
Environmental - lifestyle related factors. Best Pract Res Clin Gastroenterol (2010) 0.83
Obese patients have stronger peristalsis and increased acid exposure in the esophagus. Dig Dis Sci (2010) 0.82
Hiatal hernias: a review of the pathophysiologic theories and implication for research. Surg Endosc (2011) 0.82
Medically refractory gastroesophageal reflux disease in the obese: what is the best surgical approach? Surg Endosc (2013) 0.82
Childhood body mass index in relation to future risk of oesophageal adenocarcinoma. Br J Cancer (2015) 0.81
Prevalence of overweightedness in patients with gastro-esophageal reflux. World J Gastroenterol (2007) 0.81
Pressure details from the weight-challenged gastroesophageal junction: more than the usual suspects. Gastroenterology (2006) 0.81
Gastrointestinal issues in the assessment and management of the obese patient. Gastroenterol Hepatol (N Y) (2007) 0.80
What are Predictive Factors for Developing of Barrett's Esophagus in Patients with Gerd-our Experience. Acta Inform Med (2011) 0.80
Combined treatment of symptomatic massive paraesophageal hernia in the morbidly obese. JSLS (2011) 0.80
Esophageal Motility in the Supine and Upright Positions for Liquid and Solid Swallows Through High-resolution Manometry. J Neurogastroenterol Motil (2013) 0.80
Metabolic syndrome and gastro-esophageal reflux: A link towards a growing interest in developed countries. World J Gastrointest Pathophysiol (2010) 0.80
Physical activity and sedentary behavior in relation to esophageal and gastric cancers in the NIH-AARP cohort. PLoS One (2013) 0.79
Exercise and the Prevention of Oesophageal Cancer (EPOC) study protocol: a randomized controlled trial of exercise versus stretching in males with Barrett's oesophagus. BMC Cancer (2010) 0.79
Body mass index and the efficacy of acid-mediating agents for GERD. Dig Dis Sci (2008) 0.79
Tonic and phasic pyloric activity in response to CCK-octapeptide. Dig Dis Sci (2008) 0.78
Obesity-Related Digestive Diseases and Their Pathophysiology. Gut Liver (2016) 0.78
Republished: symptomatic reflux disease: the present, the past and the future. Postgrad Med J (2015) 0.78
Obesity and GERD. Gastroenterol Clin North Am (2013) 0.78
Diagnosis and management of Barrett's esophagus. Surg Clin North Am (2012) 0.78
Mechanism of Gastroesophageal Reflux in Obstructive Sleep Apnea: Airway Obstruction or Obesity? J Clin Sleep Med (2016) 0.78
Gastrointestinal symptoms in morbid obesity. Front Med (Lausanne) (2014) 0.78
Subtypes of metabolic syndrome and of other risk factors in Japanese women with erosive esophagitis. Medicine (Baltimore) (2014) 0.76
Transient lower oesophageal sphincter relaxation in achalasia: everything but LOS relaxation. Neurogastroenterol Motil (2009) 0.76
Overweight associated with increased risk of erosive esophagitis in a non-obese Taiwanese population. PLoS One (2013) 0.76
Gender difference in gastro-esophageal reflux diseases. World J Gastroenterol (2016) 0.76
Obesity is associated with increasing esophageal Acid exposure in korean patients with gastroesophageal reflux disease symptoms. J Neurogastroenterol Motil (2013) 0.76
Surgical management of gastroesophageal reflux disease in obesity. Dig Dis Sci (2008) 0.75
Gastroesophageal Reflux and the Obesity Epidemic. Gastroenterol Hepatol (N Y) (2006) 0.75
Hiatal hernia and the treatment of Acid-related disorders. Gastroenterol Hepatol (N Y) (2007) 0.75
Controlling on-demand gastric acidity in obese subjects: a randomized, controlled trial comparing a single dose of 20 mg rabeprazole and 20 mg omeprazole. BMC Gastroenterol (2014) 0.75
Esophageal testing: What we have so far. World J Gastrointest Pathophysiol (2016) 0.75
Gastroesophageal reflux disease and obesity: not as simple as we may think. Dig Dis Sci (2012) 0.75
Impact of obesity treatment on gastroesophageal reflux disease. World J Gastroenterol (2016) 0.75
Abdominal Visceral to Subcutaneous Adipose Tissue Ratio Is Associated with Increased Risk of Erosive Esophagitis. Dig Dis Sci (2017) 0.75
Association between visceral fat and inflammatory cytokines in reflux esophagitis. J Neurogastroenterol Motil (2015) 0.75
Sleeve Gastrectomy Combined with the Simplified Hill Repair in the Treatment of Morbid Obesity and Gastro-esophageal Reflux Disease: Preliminary Results in 14 Patients. World J Surg (2016) 0.75
Anatomical measurements of the gastric cardia in obese patients. Surg Endosc (2009) 0.75
Laparoscopic Gastric Banding: Game Over? Obes Surg (2017) 0.75
Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet (2008) 16.17
A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. Science (2002) 9.59
The RCSB Protein Data Bank: a redesigned query system and relational database based on the mmCIF schema. Nucleic Acids Res (2005) 7.81
Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology (2008) 6.73
Classifying esophageal motility by pressure topography characteristics: a study of 400 patients and 75 controls. Am J Gastroenterol (2007) 5.94
Esophageal carcinoma. N Engl J Med (2014) 5.77
The epidemiology of cholangiocarcinoma. Semin Liver Dis (2004) 5.59
Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med (2011) 4.98
The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol (2005) 4.96
The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. Dev Cell (2008) 4.90
Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci U S A (2002) 4.85
Impaired deglutitive EGJ relaxation in clinical esophageal manometry: a quantitative analysis of 400 patients and 75 controls. Am J Physiol Gastrointest Liver Physiol (2007) 4.80
Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med (2005) 4.52
Dicer is required for embryonic angiogenesis during mouse development. J Biol Chem (2004) 4.40
Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol (2004) 4.39
Biventricular pacing in patients with bradycardia and normal ejection fraction. N Engl J Med (2009) 4.17
The complete genome sequence of Mycobacterium avium subspecies paratuberculosis. Proc Natl Acad Sci U S A (2005) 4.16
Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology (2010) 3.98
DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature (2011) 3.90
Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer Cell (2011) 3.88
AGA technical review on the clinical use of esophageal manometry. Gastroenterology (2005) 3.67
Single-layer MoS2 phototransistors. ACS Nano (2011) 3.43
Quantifying esophageal peristalsis with high-resolution manometry: a study of 75 asymptomatic volunteers. Am J Physiol Gastrointest Liver Physiol (2006) 3.41
Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr (2005) 3.37
Esophageal motility disorders in terms of pressure topography: the Chicago Classification. J Clin Gastroenterol (2008) 3.36
Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate--a prospective, randomized, and controlled clinical trial. Radiology (2013) 3.32
Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology (2004) 3.30
ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. N Engl J Med (2013) 3.27
Risk factors for cholangiocarcinoma. Hepatology (2011) 3.27
Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology (2005) 3.24
Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology (2011) 3.24
Weak peristalsis in esophageal pressure topography: classification and association with Dysphagia. Am J Gastroenterol (2010) 3.15
Quantifying EGJ morphology and relaxation with high-resolution manometry: a study of 75 asymptomatic volunteers. Am J Physiol Gastrointest Liver Physiol (2006) 3.12
Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy. Circulation (2004) 3.12
Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol (2013) 3.12
The amphioxus genome illuminates vertebrate origins and cephalochordate biology. Genome Res (2008) 3.04
Human chromosome 7: DNA sequence and biology. Science (2003) 3.02
The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis (2010) 2.96
Gaps in the achievement of effectiveness of HCV treatment in national VA practice. J Hepatol (2011) 2.96
VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400. Nat Cell Biol (2008) 2.93
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol (2007) 2.90
Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc (2006) 2.89
Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol (2013) 2.89
Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nat Genet (2003) 2.78
Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc (2007) 2.77
Cost-effectiveness and diagnostic effectiveness analyses of multiple algorithms for the diagnosis of Lynch syndrome. Dig Dis Sci (2014) 2.77
Utilization of screening for hepatocellular carcinoma in the United States. J Clin Gastroenterol (2007) 2.73
Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002. Am J Gastroenterol (2007) 2.69
Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol (2005) 2.68
A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation. Hepatology (2007) 2.66
Phenotypes and clinical context of hypercontractility in high-resolution esophageal pressure topography (EPT). Am J Gastroenterol (2011) 2.66
Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology (2010) 2.64
Missed opportunities to initiate endoscopic evaluation for colorectal cancer diagnosis. Am J Gastroenterol (2009) 2.60
The Molecular Biology Toolkit (MBT): a modular platform for developing molecular visualization applications. BMC Bioinformatics (2005) 2.60
Deglutitive upper esophageal sphincter relaxation: a study of 75 volunteer subjects using solid-state high-resolution manometry. Am J Physiol Gastrointest Liver Physiol (2006) 2.57
High-resolution manometry of the EGJ: an analysis of crural diaphragm function in GERD. Am J Gastroenterol (2007) 2.56
Hyperdynamic upper esophageal sphincter pressure: a manometric observation in patients reporting globus sensation. Am J Gastroenterol (2009) 2.54
Designing a thiol specific fluorescent probe for possible use as a reagent for intracellular detection and estimation in blood serum: kinetic analysis to probe the role of intramolecular hydrogen bonding. Org Biomol Chem (2013) 2.54
Functional esophageal disorders. Gastroenterology (2006) 2.53
Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol (2003) 2.53
Utilizing intraluminal pressure differences to predict esophageal bolus flow dynamics. Am J Physiol Gastrointest Liver Physiol (2007) 2.44
Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol (2003) 2.44
Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males. Hepatology (2011) 2.42
Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004. Can J Gastroenterol (2005) 2.36
A mouse to human search for plasma proteome changes associated with pancreatic tumor development. PLoS Med (2008) 2.31
Presentation, diagnosis, and management of achalasia. Clin Gastroenterol Hepatol (2013) 2.30
Esophagogastric junction opening during relaxation distinguishes nonhernia reflux patients, hernia patients, and normal subjects. Gastroenterology (2003) 2.29
Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol (2012) 2.25
Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease. Blood (2011) 2.24
The epidemiology of obesity. Gastroenterol Clin North Am (2010) 2.23
Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet (2006) 2.22
Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation (2005) 2.22
Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis. J Natl Cancer Inst (2006) 2.21
Expression pattern shifts following duplication indicative of subfunctionalization and neofunctionalization in regulatory genes of Arabidopsis. Mol Biol Evol (2005) 2.18
Mechanical properties of the esophagus in eosinophilic esophagitis. Gastroenterology (2010) 2.10
Quantitative analysis of acrylamide labeled serum proteins by LC-MS/MS. J Proteome Res (2006) 2.10
Progression of systolic abnormalities in patients with "isolated" diastolic heart failure and diastolic dysfunction. Circulation (2002) 2.09
Elafin is a biomarker of graft-versus-host disease of the skin. Sci Transl Med (2010) 2.08
Association between surfactant protein B + 1580 polymorphism and the risk of respiratory failure in adults with community-acquired pneumonia. Crit Care Med (2004) 2.07
Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans. J Virol (2008) 2.07
Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center. Liver Transpl (2005) 2.06
Distal esophageal spasm in high-resolution esophageal pressure topography: defining clinical phenotypes. Gastroenterology (2011) 2.05
Molecular and clinical genetics of mitochondrial diseases due to POLG mutations. Hum Mutat (2008) 2.04
Global characterization of Artemisia annua glandular trichome transcriptome using 454 pyrosequencing. BMC Genomics (2009) 2.04
Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes. J Proteome Res (2007) 2.04
A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging. J Am Coll Cardiol (2005) 2.03
Increased risk for persistent intestinal metaplasia in patients with Barrett's esophagus and uncontrolled reflux exposure before radiofrequency ablation. Gastroenterology (2012) 2.02
Direct laser writing of micro-supercapacitors on hydrated graphite oxide films. Nat Nanotechnol (2011) 2.02
Partial recovery of peristalsis after myotomy for achalasia: more the rule than the exception. JAMA Surg (2013) 1.98
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol (2007) 1.96
Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligase. Cancer Cell (2010) 1.95